Papers associated with slc2a9

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Genetic and Physiological Effects of Insulin-Like Growth Factor-1 (IGF-1) on Human Urate Homeostasis., Mandal AK, Leask MP, Sumpter NA, Choi HK, Merriman TR, Mount DB., J Am Soc Nephrol. March 1, 2023; 34 (3): 451-466.
	Characterization of a Compound Heterozygous SLC2A9 Mutation That Causes Hypouricemia., Yoon J, Cachau R, David VA, Thompson M, Jung W, Jee SH, Daar IO, Winkler CA, Cho SK., Biomedicines. September 6, 2021; 9 (9):
	Genetic and Physiological Effects of Insulin on Human Urate Homeostasis., Mandal AK, Leask MP, Estiverne C, Choi HK, Merriman TR, Mount DB., Front Physiol. January 1, 2021; 12 713710.
	Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9., Arakawa H, Amezawa N, Kawakatsu Y, Tamai I., Biol Pharm Bull. January 1, 2020; 43 (11): 1792-1798.
	Dual actions on gout flare and acute kidney injury along with enhanced renal transporter activities by Yokuininto, a Kampo medicine., Lee SH, Lee HS, Park G, Oh SM, Oh DS., BMC Complement Altern Med. March 12, 2019; 19 (1): 57.
	Different Pharmacological Properties of GLUT9a and GLUT9b: Potential Implications in Preeclampsia., Lüscher BP, Surbek DV, Clémençon B, Huang X, Albrecht C, Marini C, Hediger MA, Baumann MU., Cell Physiol Biochem. January 1, 2019; 53 (3): 508-517.
	Interaction Between ITM2B and GLUT9 Links Urate Transport to Neurodegenerative Disorders., Mandal AK, Mount DB., Front Physiol. January 1, 2019; 10 1323.
	URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia., Claverie-Martin F, Trujillo-Suarez J, Gonzalez-Acosta H, Aparicio C, Justa Roldan ML, Stiburkova B, Ichida K, Martín-Gomez MA, Herrero Goñi M, Carrasco Hidalgo-Barquero M, Iñigo V, Enriquez R, Cordoba-Lanus E, Garcia-Nieto VM, RenalTube Group., Clin Chim Acta. June 1, 2018; 481 83-89.
	GLUT Characterization Using Frog Xenopus laevis Oocytes., Long W, O'Neill D, Cheeseman CI., Methods Mol Biol. January 1, 2018; 1713 45-55.
	Human Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate., Ruiz A, Gautschi I, Schild L, Bonny O., Front Physiol. January 1, 2018; 9 476.
	Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters., Ebert K, Ludwig M, Geillinger KE, Schoberth GC, Essenwanger J, Stolz J, Daniel H, Witt H., J Membr Biol. April 1, 2017; 250 (2): 171-182.
	Uricosuric targets of tranilast., Mandal AK, Mercado A, Foster A, Zandi-Nejad K, Mount DB., Pharmacol Res Perspect. February 6, 2017; 5 (2): e00291.
	Identification of Key Residues for Urate Specific Transport in Human Glucose Transporter 9 (hSLC2A9)., Long W, Panigrahi R, Panwar P, Wong K, O Neill D, Chen XZ, Lemieux MJ, Cheeseman CI., Sci Rep. January 24, 2017; 7 41167.
	Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2., Mancikova A, Krylov V, Hurba O, Sebesta I, Nakamura M, Ichida K, Stiburkova B., Clin Exp Nephrol. August 1, 2016; 20 (4): 578-584.
	Hereditary Renal Hypouricemia Type 1 and Autosomal Dominant Polycystic Kidney Disease., Stiburkova B, Stekrova J, Nakamura M, Ichida K., Am J Med Sci. October 1, 2015; 350 (4): 268-71.
	SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria., Chino Y, Samukawa Y, Sakai S, Nakai Y, Yamaguchi J, Nakanishi T, Tamai I., Biopharm Drug Dispos. October 1, 2014; 35 (7): 391-404.
	Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system., Clémençon B, Lüscher BP, Fine M, Baumann MU, Surbek DV, Bonny O, Hediger MA., PLoS One. January 1, 2014; 9 (10): e108852.
	Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout., Hurba O, Mancikova A, Krylov V, Pavlikova M, Pavelka K, Stibůrková B., PLoS One. January 1, 2014; 9 (9): e107902.
	Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis., Stiburkova B, Sebesta I, Ichida K, Nakamura M, Hulkova H, Krylov V, Kryspinova L, Jahnova H., Eur J Hum Genet. October 1, 2013; 21 (10): 1067-73.
	Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate., Nakanishi T, Ohya K, Shimada S, Anzai N, Tamai I., Nephrol Dial Transplant. March 1, 2013; 28 (3): 603-11.
	Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses., Witkowska K, Smith KM, Yao SY, Ng AM, O'Neill D, Karpinski E, Young JD, Cheeseman CI., Am J Physiol Renal Physiol. August 15, 2012; 303 (4): F527-39.
	Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2., Dinour D, Gray NK, Ganon L, Knox AJ, Shalev H, Sela BA, Campbell S, Sawyer L, Shu X, Valsamidou E, Landau D, Wright AF, Holtzman EJ., Nephrol Dial Transplant. March 1, 2012; 27 (3): 1035-41.
	URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews., Dinour D, Bahn A, Ganon L, Ron R, Geifman-Holtzman O, Knecht A, Gafter U, Rachamimov R, Sela BA, Burckhardt G, Holtzman EJ., Nephrol Dial Transplant. July 1, 2011; 26 (7): 2175-81.
	Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate., Jutabha P, Anzai N, Kitamura K, Taniguchi A, Kaneko S, Yan K, Yamada H, Shimada H, Kimura T, Katada T, Fukutomi T, Tomita K, Urano W, Yamanaka H, Seki G, Fujita T, Moriyama Y, Yamada A, Uchida S, Wempe MF, Endou H, Sakurai H., J Biol Chem. November 5, 2010; 285 (45): 35123-32.
	Homozygous SLC2A9 mutations cause severe renal hypouricemia., Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, Richardson W, Rechavi G, Amariglio N, Ganon L, Sela BA, Bahat H, Goldman M, Weissgarten J, Millar MR, Wright AF, Holtzman EJ., J Am Soc Nephrol. January 1, 2010; 21 (1): 64-72.
	Solute carrier family 2, member 9 and uric acid homeostasis., Cheeseman C., Curr Opin Nephrol Hypertens. September 1, 2009; 18 (5): 428-32.
	Mouse GLUT9: evidences for a urate uniporter., Bibert S, Hess SK, Firsov D, Thorens B, Geering K, Horisberger JD, Bonny O., Am J Physiol Renal Physiol. September 1, 2009; 297 (3): F612-9.
	SLC2A9 is a high-capacity urate transporter in humans., Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, Doblado M, Evans S, Eyheramendy S, Onipinla A, Howard P, Shaw-Hawkins S, Dobson RJ, Wallace C, Newhouse SJ, Brown M, Connell JM, Dominiczak A, Farrall M, Lathrop GM, Samani NJ, Kumari M, Marmot M, Brunner E, Chambers J, Elliott P, Kooner J, Laan M, Org E, Veldre G, Viigimaa M, Cappuccio FP, Ji C, Iacone R, Strazzullo P, Moley KH, Cheeseman C., PLoS Med. October 7, 2008; 5 (10): e197.
	Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans., Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, Srivastava S, Kitamura K, Hisatome I, Endou H, Sakurai H., J Biol Chem. October 3, 2008; 283 (40): 26834-8.
	SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout., Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, Donnelly LA, Fairbanks LD, Aringer M, McKeigue PM, Ralston SH, Morris AD, Rudan P, Hastie ND, Campbell H, Wright AF., Nat Genet. April 1, 2008; 40 (4): 437-42.
	Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes., Keembiyehetty C, Augustin R, Carayannopoulos MO, Steer S, Manolescu A, Cheeseman CI, Moley KH., Mol Endocrinol. March 1, 2006; 20 (3): 686-97.
	Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking., Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH., J Biol Chem. April 16, 2004; 279 (16): 16229-36.
	Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1., Dawson PA, Mychaleckyj JC, Fossey SC, Mihic SJ, Craddock AL, Bowden DW., Mol Genet Metab. January 1, 2001; 74 (1-2): 186-99.

???pagination.result.page??? 1